Effects of Aripiprazole in Overweight Patients Treated With Olanzapine for Schizophrenia or Schizoaffective Disorder

Clinical trial NCT00095524 · COMPLETED

Trial details

NCT number: NCT00095524
Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Body Weight Change Schizophrenia Schizoaffective Disorder Psychotic Disorder

Start date: 2004-03-01
Primary completion: 2006-08-01
Enrollment: 300

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.